Company profile
VPM is a private vaccine and biopharmaceutical development company with a high potential for value creation. The company was founded in August 2002 and is based in Hannover. Germany.
VPMīs product portfolio targets combined markets of over 6 billion in cancer, multiple sclerosis and infectious diseases. Each product is developed together with partners with specific expertise in the respective field. VPM does not bind capital in own laboratories or plants, but focuses on efficient management of itīs projects. In general VPM holds worldwide exclusive licence for all of its product.
Together with itīs consortium partners VPM also offers services to third parties.
Mission
Vakzine Projekt Management GmbH (VPM)
acquires promising vaccine candidates
from academia, develops them
with a consortium of partners
and commercializes the results
|
 |
